학술논문
Exenatide twice daily versus glimepiride for prevention of glycaemic deterioration in patients with type 2 diabetes with metformin failure (EUREXA): an open-label, randomised controlled trial.
Document Type
Journal Article
Author
Source
Subject
Language
ISSN
0140-6736